Rosiglitazone and Cardiovascular Risk

被引：0
|
作者：
Kintscher, U. [1 ]
机构：
[1] Charite Univ Med Berlin, Ctr Cardiovasc Res, Inst Pharmakol, Hessische Str 3-4, D-10115 Berlin, Germany
来源：
KARDIOLOGE | 2007年 / 1卷 / 02期
关键词：
D O I：
10.1007/s12181-007-0017-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 141
页数：3
相关论文
共 50 条
  • [1] Rosiglitazone and cardiovascular risk
    Psaty, Bruce M.
    Furberg, Curt D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24): : 2522 - 2524
  • [2] Rosiglitazone and Cardiovascular Risk
    Kaul, Sanjay
    Diamond, George A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (05) : 398 - 404
  • [3] Rosiglitazone and cardiovascular risk
    Sanjay Kaul
    George A. Diamond
    Current Atherosclerosis Reports, 2008, 10 : 398 - 404
  • [4] Rosiglitazone and cardiovascular risk - Reply
    Psaty, Bruce M.
    Furberg, Curt D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09): : 940 - 940
  • [5] Breaking news! Rosiglitazone and cardiovascular risk
    Sanjay Kaul
    George A. Diamond
    Nature Reviews Cardiology, 2010, 7 : 670 - 672
  • [6] Cardiovascular risk of rosiglitazone: another perspective
    Waksman, Javier C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (12) : 1573 - 1582
  • [7] Rosiglitazone and the Risk of Adverse Cardiovascular Outcomes
    Winterstein, A. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 776 - 778
  • [8] Is There Clear and Convincing Evidence of Cardiovascular Risk with Rosiglitazone?
    Kaul, S.
    Diamond, G. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 773 - 776
  • [9] Rosiglitazone effects on cardiovascular risk factors and ischemia
    Raji, A
    Di Carli, M
    Seidl, K
    Stone, P
    Plutzky, J
    DIABETES, 2003, 52 : A472 - A472
  • [10] Systematic review: cardiovascular risk and mortality with rosiglitazone
    Reactions Weekly, 2020, 1791 (1) : 13 - 13
12345